Top Growth Trends in the Stelara (Ustekinumab) Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theStelara (Ustekinumab) Market?
An increase in the number of individuals suffering from psoriasis is anticipated to propel the stelara (ustekinumab) market’s growth. Patients with psoriasis endure a persistent autoimmune disorder that accelerates the turnover of skin cells, leading to red, scaly skin patches. The increased incidence of psoriasis can be associated with multiple factors like improved diagnostic procedures, environmental triggers, genetic factors, and an older population demographic. Interleukin-12 and interleukin-23, targeted and inhibited by stelara (ustekinumab), help these patients by efficaciously reducing inflammation, restricting plaque formation, and promoting enhanced skin clarity and long-term symptom management, ultimately improving their life quality. For instance, a report released by the National Library of Medicine, a medical library based in the US, revealed in May 2024 that psoriasis prevalence had grown to 0.221% in 2022, with a documented 6,930 PsA instances in a populace of 3,133,500. Thus, escalating psoriasis prevalence is forecasted to significantly drive the stelara (ustekinumab) market’s growth.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19935&type=smp
How Has the Stelara (Ustekinumab) Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
The stelara (ustekinumab) market has expanded significantly, moving from $11,177.34 million in 2024 to $11,850.79 million in 2025 at a CAGR of 6.0%. Growth was driven by increased healthcare budgets, the rise of specialty drug channels, broader clinical research efforts, higher R&D investments, and telemedicine-based treatment access.
The stelara (ustekinumab) market will reach $14,768.48 million by 2029 with a 5.7% CAGR, fueled by wider usage in autoimmune disorders and its effectiveness in refractory cases. Trends include biologics innovation, new delivery methods, and pharma collaborations.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19935
What Are the Current Market Growth and Trends in theStelara (Ustekinumab) Market That Industry Players Should Watch?
One significant trend within the Stelara (Ustekinumab) market is the development of innovative substitutes like biosimilars to Stelara, offering more affordable cure alternatives for patients with chronic inflammatory illnesses. Biosimilars of Stelara are bio-equivalent drugs crafted to copy the therapeutic properties of Stelara (Ustekinumab), influencing IL-12 and IL-23 to combat autoimmune diseases like psoriasis and psoriatic arthritis. For example, Accord BioPharma Inc., a biopharmaceutical firm based in the United States, unveiled in October 2024 the U.S. Food and Drug Administration’s (FDA) approval for IMULDOSA (ustekinumab-srlf), a biosimilar to Johnson & Johnson’s STELARA (ustekinumab). IMULDOSA is recognized for its extensive indications, catering to adult patients suffering from moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn’s disease, and ulcerative colitis. Moreover, it’s distinctly prescribed for pediatric patients at least six years old suffering from moderate to severe plaque psoriasis and active psoriatic arthritis, making it adaptable for various age groups. Such extensive adaptability places IMULDOSA as an invaluable solution for controlling different immune-mediated inflammatory disorders.
What Are the Major Market Players Making an Impact on theStelara (Ustekinumab) Market Growth?
Major companies operating in the stelara (ustekinumab) market include Johnson & Johnson
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/stelara-ustekinumab-global-market-report-
How Are the Key Segments of the Stelara (Ustekinumab) Market Driving Opportunities and Innovations?
The stelara (ustekinumab)market covered in this report is segmented –
1) By Indication: Plaque Psoriasis; Psoriatic Arthritis; Crohn’s Disease; Ulcerative Colitis; Other Indications
2) By Route Of Administration: Subcutaneous Injection; Intravenous Infusion
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
4) By End User: Pediatric; Adult; Geriatric
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=19935&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theStelara (Ustekinumab) Market?# Market Expansion?
North America was the largest region in the stelara (ustekinumab) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stelara (ustekinumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Stelara (Ustekinumab) Market 2025, By The Business Research Company:
Psoriasis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
Radiosurgery And Radiotherapy Robotics Global Market Report 2025
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
